Biovet JSC (LTS:0III) Other Current Assets: лв2.84 Mil (As of Dec. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biovet JSC Other Current Assets?

Biovet JSC LTS:0III Other Current Assets is лв2.84 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's other current assets for the quarter that ended in Dec. 2016 was лв2.84 Mil.

Biovet JSC's quarterly other current assets declined from Jun. 2016 (лв6.33 Mil) to Sep. 2016 (лв4.46 Mil) and declined from Sep. 2016 (лв4.46 Mil) to Dec. 2016 (лв2.84Mil).

Biovet JSC's annual other current assets increased from Dec. 2014 (лв1.74 Mil) to Dec. 2015 (лв3.95 Mil) declined from Dec. 2015 (лв3.95 Mil) to Dec. 2016 (лв2.84 Mil).


Biovet JSC Other Current Assets Related Terms


Biovet JSC Other Current Assets Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Other Current Assets Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Other Current Assets
Get a 7-Day Free Trial 1.51 1.52 1.74 3.95 2.84

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 5.67 6.33 4.46 2.84

Biovet JSC Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of лв2.84 Mil mean?
Biovet JSC (LTS:0III) has a Other Current Assets of лв2.84 Mil as of Dec. 2016. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Biovet JSC.
Is Biovet JSC's Other Current Assets too high?
Biovet JSC's current Other Current Assets is лв2.84 Mil.
How does Biovet JSC's Other Current Assets compare to ADMP and AGRX?
Biovet JSC's Other Current Assets of лв2.84 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Drug Manufacturers company?
A good Other Current Assets depends on the Drug Manufacturers industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Biovet JSC. Biovet JSC's current Other Current Assets is лв2.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Other Current Assets of лв2.84 Mil. The current Other Current Assets is лв2.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Other Current Assets is лв2.84 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.